Coherus Biosciences Inc. (CHRS)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Oaktree Capital ManagementCONVERTIBLE BOND

Howard Marks

49,030,000 $48,294,369 0.93%
2.
Deepcurrents Investment GroupNOTE 1.500% 4/1

Steve Zheng

28,338,000 $27,558,960 +254% 0.85%
3.
Highbridge Capital ManagementBOND

Glenn Russell Dubin

17,647,000 $17,294,060 0.7%
4.
ADAR1 Capital ManagementNOTE 1.500% 4/1

Daniel Schneeberger

5,625,000 $5,484,375 1.02%
5.
D E ShawNOTE 1.500% 4/1

D. E. Shaw

4,500,000 $4,405,575 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$13.42 3,700 Officer 35,118 2021-06-09 Filing
$13.50 425,926 Director 2,557,759 2014-11-12 Filing
$13.50 164,963 Other 3,042,019 2014-11-12 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$2.02 223,100 731,693 2023-11-22 Filing
$16.80 3,507 Officer 31,611 2021-10-15 Filing
$16.12 286,076 Director 0 2021-09-29 Filing
$17.17 48,329 Director 286,076 2021-09-28 Filing
$18.06 100,150 Director 334,405 2021-09-27 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 58,249 $57,375,032 2.22%
2. 11,151,905 $8,999,588 0%
3. 10,978,359 $8,859,535 0%
4. 3,036,076 $2,409,974 0.05%
5. 2,655,500 $2,143,452 0%
News See All